Michael Klichinsky
Fundador en CARISMA THERAPEUTICS, INC. .
Fortuna: 644 182 $ al 31/05/2024
Cargos activos de Michael Klichinsky
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/04/2022 | - |
| Fundador | 01/01/2016 | - | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Director Técnico/Científico/I+D | 01/04/2022 | - |
| Fundador | 01/01/2016 | - | |
| Corporate Officer/Principal | 01/10/2018 | 01/04/2022 |
Historial de carrera de Michael Klichinsky
Formación de Michael Klichinsky.
| University of Pennsylvania | Doctorate Degree |
| University of the Sciences in Philadelphia | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Doctorate Degree | 2 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Klichinsky
- Experiencia
